(doxorubicin hydrochloride)
Doxorubicin Hydrochloride Injection, is available as follows:
Doxorubicin Hydrochloride Injection is a sterile, isotonic solution, available in single-dose polypropylene (CYTOSAFE)® vials, and multiple-dose polypropylene (CYTOSAFE)® vials:
Unit of Sale | Total Strength/Total Volume (Concentration) |
NDC 0069-3030-20 Carton of 1 Single-dose Vial | 10 mg/5 mL (2 mg/mL) |
NDC 0069-3031-20 Carton of 1 Single-dose Vial | 20 mg/10 mL (2 mg/mL) |
NDC 0069-3032-20 Carton of 1 Single-dose Vial | 50 mg/25 mL (2 mg/mL) |
NDC 0069-3033-20 Carton of 1 Multiple-dose Vial | 150 mg/75 mL (2 mg/mL) |
NDC 0069-3034-20 Carton of 1 Multiple-dose Vial | 200 mg/100 mL (2 mg/mL) |
Retain in carton until contents are used. For single-dose vials, discard unused portion.
Doxorubicin Hydrochloride Injection is a sterile, isotonic solution, available in single-dose ONCO-TAIN® glass vials, and multiple-dose ONCO-TAIN® glass vials:
Unit of Sale | Total Strength/Total Volume (Concentration) |
NDC 0069-0358-20 Carton of 1 Single-dose Vial | 10 mg/5 mL (2 mg/mL) |
NDC 0069-0277-02 Carton of 1 Single-dose Vial | 20 mg/10 mL (2 mg/mL) |
NDC 0069-0343-02 Carton of 1 Single-dose Vial | 50 mg/25 mL (2 mg/mL) |
NDC 0069-1542-20 Carton of 1 Multiple-dose Vial | 200 mg/100 mL (2 mg/mL) |
ONCO-TAIN® is the vial external protection system.
Retain in carton until contents are used. For single-dose ONCO-TAIN® glass vials, discard unused portion.
Storage
Store all vials at 2°C to 8°C (36°F to 46°F). Protect from light.
Storage of Doxorubicin Hydrochloride Injection under refrigerated conditions can result in the formation of a gelled product. Place gelled product at room temperature [15ºC to 30ºC (59ºF to 86ºF)] for 2 to 4 hours to return the product to a slightly viscous, mobile solution.
{{section_name_patient}}
{{section_body_html_patient}}
Additional Resources
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.
Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.
Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for a Pfizer medicine or a vaccine.
The submission will be reviewed during our standard business hours.
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.